Key Finding
Acupuncture was identified as a well-accepted non-hormonal, non-pharmacological alternative therapy for managing menopausal symptoms in middle-aged women.
This systematic review examined how alternative therapies can help women manage menopause symptoms and improve their quality of life. Researchers searched major medical databases to identify studies on non-hormonal approaches to treating common menopause complaints like hot flashes, mood changes, sleep problems, and sexual dysfunction.
The review found that several alternative therapies show promise for managing menopause symptoms. Acupuncture was highlighted as a well-accepted non-hormonal, non-drug treatment option for various menopause-related concerns. The researchers also identified benefits from dietary interventions including foods like fennel, soy, black cohosh, St. John's wort, red clover, and date pollen, which appear to help with hot flashes and sexual dysfunction. Aromatherapy using essential oils such as lavender, neroli, fennel, rose, and geranium through inhalation or massage was found to balance cortisol levels and reduce stress and anxiety. Additionally, yoga therapy showed positive effects on both psychological symptoms (like mood and anxiety) and physical symptoms by influencing neurohormonal pathways. Exercise was also identified as beneficial.
The research suggests that women experiencing menopause have multiple evidence-based options beyond hormone replacement therapy. These alternative approaches—including acupuncture, specific dietary changes, aromatherapy, yoga, and exercise—can be used alone or alongside conventional treatments to manage the decreased estrogen and progesterone levels that cause menopause symptoms. The review emphasizes that these therapies may help prevent long-term complications like osteoporosis and cardiovascular disease. If you're considering acupuncture for menopause symptoms, seek treatment from a licensed acupuncturist with experience in women's health.
This systematic review analyzed alternative therapeutic approaches for managing menopausal symptoms and improving quality of life in middle-aged women. The authors systematically searched major electronic databases and synthesized evidence on non-hormonal, non-pharmacological interventions. Key findings identified acupuncture as a well-accepted alternative to hormone replacement therapy for managing hypo-estrogenic symptoms. The review consolidated evidence supporting multiple modalities: dietary interventions (fennel, soy, black cohosh, St. John's wort, red clover, date pollen) for vasomotor symptoms and sexual dysfunction; aromatherapy with essential oils (lavender, neroli, fennel, rose, geranium) for cortisol regulation and stress reduction; and yoga therapy affecting neurohormonal pathways to address both psychological and physiological symptoms. Exercise was also supported as beneficial. Clinical takeaway: This review provides evidence-based rationale for recommending acupuncture as part of an integrative approach to menopause management, particularly for patients seeking alternatives to HRT. The synthesis supports multi-modal treatment protocols combining acupuncture with lifestyle modifications for optimal outcomes in managing vasomotor, psychological, and genitourinary symptoms.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 Dysregulation of m7G RNA modifications, catalyzed by three major methyltransferase complexes in the CNS, is associated with the pathogenesis of multiple neurological diseases including Alzheimer's disease, ALS, epilepsy, glioblastoma, and ischemic stroke.
📌 Acupuncture significantly reduced thyroid antibodies (TPOAb and TGAb) and TSH levels in Hashimoto thyroiditis patients, though methodological limitations prevent reliable clinical recommendations pending higher-quality research.
📌 Liproxstatin-1 significantly reduced cerebral ischemia-reperfusion injury in rats by inhibiting ferroptosis through increasing neuroprotective factors GPX4 and FTH1 while decreasing ferroptosis markers NOX1, ACSL4, COX2, and TFR1.